Context Therapeutics (CNTX) Times Interest Earned (2020 - 2026)
Context Therapeutics (CNTX) posted Times Interest Earned of -$0.99 for Q1 2026, up 78.97% sequentially from -$4.69 in Q4 2025.
Context Therapeutics (CNTX) Times Interest Earned (2020 - 2026) Analysis & Trends
Context Therapeutics has reported Times Interest Earned for 7 years, with the latest figure at -$0.99 in Q1 2026.
- Quarterly Times Interest Earned changed N/A year-over-year to -$0.99 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.6 (changed N/A YoY) and the FY2025 annual result came in at -$1.11, up 8.5% from the prior year.
- Times Interest Earned rose to -$0.99 in Q1 2026 per CNTX's latest filing, from -$4.69 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.17 in Q4 2024 and troughed at -$4611.7 in Q2 2025.
- A 5-year average of -$389.61 and a median of -$5.11 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned soared 99.69% in 2022, then tumbled 271072.45% in 2025.
- Over 5 years, Times Interest Earned stood at -$0.42 in 2022, then grew by 1.15% to -$0.42 in 2023, then soared by 58.3% to -$0.17 in 2024, then plunged by 2595.57% to -$4.69 in 2025, then jumped by 78.97% to -$0.99 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.99, -$4.69, and -$14.9 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Context Therapeutics | 48.18 Mn | 48.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.99 |
| Dec 31, 2025 | -4.69 |
| Sep 30, 2025 | -14.90 |
| Jun 30, 2025 | -4,611.70 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | -10.90 |
| Jun 30, 2024 | -1.70 |
| Mar 31, 2024 | -5.53 |
| Dec 31, 2023 | -0.42 |
| Sep 30, 2023 | -10.13 |
| Jun 30, 2023 | -13.73 |
| Dec 31, 2022 | -0.42 |
| Dec 31, 2021 | -134.43 |
| Sep 30, 2021 | -34.09 |
| Jun 30, 2021 | -218.50 |
| Mar 31, 2021 | -2.80 |
| Dec 31, 2020 | -8.15 |
| Sep 30, 2020 | -6.84 |